SUTAB 1.479-0.225-0.188 GM TAB
FDA nonproprietary name: sodium sulfate, magnesium sulfate, and potassium chloride
For 30 tablets
Pharmacies pay
$202.18 filed
30 × $6.73948 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-08-05 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$202.16 filed
30 × $6.73874 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.0× estimated
Medicare paid about what pharmacies pay.
Part D averages every strength and form sold under “Sutab” / “Sod Sulf/Pot Chloride/Mag Sulf” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-17, 2026-08-05 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$237.51 estimated
$202.18 + $30.33 (15%) + $5.00 fee per fill = $237.51
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-17, 2026-08-05 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
SUTAB 1.479-0.225-0.188 GM TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as sodium sulfate, magnesium sulfate, and potassium chloride, under the trade name “SUTAB”.
FDA gives its dosage form as tablet and its route as oral.
Its labelers, the companies named on the label, are Azurity Pharmaceuticals, Inc. and Braintree Laboratories, Inc.
FDA lists it under 3 Established Pharmacologic Classes: Calculi Dissolution Agent, Osmotic Laxative and Potassium Salt.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $202.18 for 30 tablets (30 × $6.73948 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-06-17 and 2026-08-05. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 2, the latest survey was within 2% of the current NADAC, so the NADAC was carried forward from the previous file.
The NADAC of all 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-06-17, 2026-08-05. The file is new; the price is not.
What NADAC measures · Why 30 tablets · NADAC explanation codes · Carried-forward prices
All 2 NDCs
- 24338-0201-01 · Azurity Pharmaceuticals, Inc. · $6.73948 per EA · eff. 2026-08-05 filed carried forward
- 52268-0201-01 · Braintree Laboratories, Inc. · $6.73948 per EA · eff. 2026-06-17 filed carried forward
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $6.73948 per EA filed.
Of the 20 other products in FDA’s Calculi Dissolution Agent class priced per EA, 2 have a higher middle NADAC price and 18 a lower one. The one in the middle is GNP DUAL ACTN COMPLETE TB CHEW, at $0.2578 per EA filed (eff. 2026-09-23).
Of the 43 other products in FDA’s Osmotic Laxative class priced per EA, 7 have a higher middle NADAC price and 36 a lower one. The one in the middle is KLOR-CON M15 TABLET, at $0.49604 per EA filed (eff. 2026-09-23).
Of the 16 other products in FDA’s Potassium Salt class priced per EA, 1 has a higher middle NADAC price and 15 a lower one. The one in the middle is POTASSIUM CL ER 20 MEQ TABLET, at $0.14078 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-05, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $202.16 for 30 tablets, at an average of $6.73874 per EA in 2024 (2024-01-01 to 2024-12-31) for “Sutab” and “Sod Sulf/Pot Chloride/Mag Sulf”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 156,816 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for SUTAB 1.479-0.225-0.188 GM TAB labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Sutab / Sod Sulf/Pot Chloride/Mag Sulf: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Related pages
Its pharmacologic classes
Related in the same class
- SOD SUL-POTASS SUL-MAG SUL SOL
- PEG-3350 AND ELECTROLYTES SOLN
- CLENPIQ 175 ML SOLUTION
- GAVILYTE-N SOLUTION
- EFFER-K 10 MEQ TABLET EFF